WIGGANS THOMAS G

CIK 000120890713 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001208907

Recent Transactions

50 trades

Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2025-09-22$2.43/sh+41,000→ 41,000 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Common Stock Warrant (right to buy)
2025-09-22+41,000→ 41,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2025-07-03+7,500→ 7,500 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-06-05+55,000→ 55,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2024-06-06+7,500→ 7,500 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2024-06-05+44,000→ 44,000 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−14,010→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−67,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−25,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−80,000→ 0 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2024-01-24+14,010→ 14,010 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-11-28$0.65/sh+10,000→ 50,000 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-11-21$0.64/sh+10,000→ 40,000 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-11-20$0.63/sh+10,000→ 30,000 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-11-17$0.60/sh+10,000→ 20,000 total
Purchase
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-11-16$0.60/sh+10,000→ 10,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2023-11-01+110,000→ 110,000 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−562,500→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−985,000→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−450,000→ 0 total
Disposition from Tender
PARDES BIOSCIENCES, INC.
Common Stock
2023-08-31−50,000→ 0 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2023-06-08+24,000→ 24,000 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-02-01+562,500→ 562,500 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2023-01-25+25,000→ 25,000 total
Purchase
PARDES BIOSCIENCES, INC.
Common Stock
2022-12-05$1.09/sh+12,500→ 50,000 total
Purchase
PARDES BIOSCIENCES, INC.
Common Stock
2022-12-02$1.07/sh+12,500→ 37,500 total
Purchase
PARDES BIOSCIENCES, INC.
Common Stock
2022-12-01$1.04/sh+25,000→ 25,000 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−8,375→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−25,000→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−6,750→ 0 total
Disposition from Tender
Forma Therapeutics Holdings, Inc.
Common Stock
2022-10-14−7,250→ 0 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2022-09-14+450,000→ 450,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2022-06-09+24,000→ 24,000 total
Award
Forma Therapeutics Holdings, Inc.
Common Stock
2022-06-08+4,500→ 7,250 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-06-08+6,750→ 6,750 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2022-03-02+985,000→ 985,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2022-01-25+67,000→ 67,000 total
Award
Forma Therapeutics Holdings, Inc.
Common Stock
2021-06-17+2,750→ 2,750 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-06-17+8,375→ 8,375 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2021-06-02+10,000→ 10,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2021-04-05+80,000→ 80,000 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2020-09-07+25,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−15,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Employee Stock Options (Right to buy)
2020-02-20−300,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Common Stock
2020-02-20$18.75/sh−180,985→ 0 total
Disposition to Issuer
Dermira, Inc.
Stock Options (Right to buy)
2020-02-20−180,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−9,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Stock Options (Right to buy)
2020-02-20−64,327→ 0 total
Disposition to Issuer
Dermira, Inc.
Employee Stock Options (Right to buy)
2020-02-20−150,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−50,000→ 0 total

Companies

Recent Filings

Address

C/O PEPLIN, INC. 6475 CHRISTIE AVENUE

EMERYVILLE, CA, 94608

View on SEC.gov